Nevertheless, the inhibitor TG003 effectively controlled the growth of tumours and suppressed the expression of CLASRP in vivo, suggesting that CLASRP is a promotional oncogene that could be regulated by Clk inhibitors. This evidence concerns the gene CLASRP and neoplasm.